Hohberger B, Schlotzer-Schrehard U, Mardin C, Lammer R, Munoz L, Kunze R
Front Neurosci. 2021; 15:676579.
PMID: 34421514
PMC: 8377674.
DOI: 10.3389/fnins.2021.676579.
Yoon D, Kaur R, Gallegos A, West K, Yang H, Schaefer S
Am J Clin Dermatol. 2020; 22(1):89-99.
PMID: 33237496
DOI: 10.1007/s40257-020-00567-3.
Prokai L, Zaman K, Nguyen V, Prokai-Tatrai K
Pharmaceutics. 2020; 12(2).
PMID: 32012756
PMC: 7076522.
DOI: 10.3390/pharmaceutics12020101.
Kazemi A, McLaren J, Trese M, Toris C, Gulati V, Fan S
Am J Ophthalmol. 2019; 202:126-132.
PMID: 30794789
PMC: 6548641.
DOI: 10.1016/j.ajo.2019.02.014.
Junemann A, Hohberger B, Rech J, Sheriff A, Fu Q, Schlotzer-Schrehardt U
Front Immunol. 2018; 9:145.
PMID: 29483909
PMC: 5816038.
DOI: 10.3389/fimmu.2018.00145.
Role of cyclic AMP in the eye with glaucoma.
Shim M, Kim K, Ju W
BMB Rep. 2016; 50(2):60-70.
PMID: 27916026
PMC: 5342868.
DOI: 10.5483/bmbrep.2017.50.2.200.
Quadrant Field Pupillometry Detects Melanopsin Dysfunction in Glaucoma Suspects and Early Glaucoma.
Adhikari P, Zele A, Thomas R, Feigl B
Sci Rep. 2016; 6:33373.
PMID: 27622679
PMC: 5020729.
DOI: 10.1038/srep33373.
The intraocular pressure-lowering properties of intravenous paracetamol.
van den Heever H, Meyer D
Clin Ophthalmol. 2016; 10:1283-9.
PMID: 27471373
PMC: 4948718.
DOI: 10.2147/OPTH.S87988.
Effect of preservative removal from fixed-combination bimatoprost/timolol on intraocular pressure lowering: a potential timolol dose-response phenomenon.
Shen J, Bejanian M
Clin Ophthalmol. 2016; 10:373-83.
PMID: 27041984
PMC: 4780662.
DOI: 10.2147/OPTH.S98898.
Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions.
Donegan R, Lieberman R
J Med Chem. 2015; 59(3):788-809.
PMID: 26356532
PMC: 5547565.
DOI: 10.1021/acs.jmedchem.5b00828.
Efficacy and safety of brinzolamide/timolol fixed combination compared with timolol in Japanese patients with open-angle glaucoma or ocular hypertension.
Yoshikawa K, Kozaki J, Maeda H
Clin Ophthalmol. 2014; 8:389-99.
PMID: 24550667
PMC: 3926459.
DOI: 10.2147/OPTH.S58293.
Mechanism and site of inhibition of AMPA receptors: pairing a thiadiazole with a 2,3-benzodiazepine scaffold.
Wang C, Han Y, Wu A, Solyom S, Niu L
ACS Chem Neurosci. 2013; 5(2):138-47.
PMID: 24313227
PMC: 3930993.
DOI: 10.1021/cn400193u.
Myopia: attempts to arrest progression.
Saw S, Gazzard G, Au Eong K, Tan D
Br J Ophthalmol. 2002; 86(11):1306-11.
PMID: 12386095
PMC: 1771373.
DOI: 10.1136/bjo.86.11.1306.
A comparative study on the effects of apraclonidine and timolol on the ophthalmic blood flow velocity waveforms.
Oruc S, Sener E
Int Ophthalmol. 2001; 23(2):69-73.
PMID: 11196122
DOI: 10.1023/a:1026531304687.
Role of cyclic AMP-induced Cl conductance in aqueous humour formation by the dog ciliary epithelium.
Chen S, Inoue R, Inomata H, Ito Y
Br J Pharmacol. 1994; 112(4):1137-45.
PMID: 7952875
PMC: 1910227.
DOI: 10.1111/j.1476-5381.1994.tb13202.x.
Timolol in operated closed-angle glaucoma.
Phillips C
Br J Ophthalmol. 1980; 64(4):240-6.
PMID: 7387959
PMC: 1043664.
DOI: 10.1136/bjo.64.4.240.
Epinephrine distribution after topical administration to phakic and aphakic eyes.
Kramer S
Trans Am Ophthalmol Soc. 1980; 78:947-82.
PMID: 7257075
PMC: 1312163.
Effects of timolol on corneal sensitivity and tear production.
Kitazawa Y, Tsuchisaka H
Int Ophthalmol. 1980; 3(1):25-9.
PMID: 7216626
DOI: 10.1007/BF00136210.
The IOP-lowering effect of timolol in simple and capsular glaucoma. A multicenter study in Finland.
Takki K, Klemetti A, VALLE O
Graefes Arch Clin Exp Ophthalmol. 1982; 218(2):83-7.
PMID: 7075965
DOI: 10.1007/BF02153716.
Study of the additive effect of timolol and epinephrine in lowering intraocular pressure.
Thomas J, Epstein D
Br J Ophthalmol. 1981; 65(9):596-602.
PMID: 7028085
PMC: 1039603.
DOI: 10.1136/bjo.65.9.596.